|
Gene description for IGLV2-11 |
| Gene name |
immunoglobulin lambda variable 2-11 |
| Gene symbol |
IGLV2-11 |
| Other names/aliases |
IGLV211 V1-3 |
| Species |
Homo sapiens |
Database cross references - IGLV2-11 |
| ExoCarta |
ExoCarta_28816 |
| Vesiclepedia |
VP_28816 |
| Entrez Gene |
28816 |
| HGNC |
5887 |
IGLV2-11 identified in sEVs derived from the following tissue/cell type |
|
Mesenchymal stem cells
|
Unpublished / Not applicable
|
|
Mesenchymal stem cells
|
36408942
|
|
Saliva
|
19199708
|
Gene ontology annotations for IGLV2-11 |
|
|
Experiment description of studies that identified IGLV2-11 in sEVs |
| 1 |
| Experiment ID |
126 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry [LTQ-FT Ultra]
|
| PubMed ID |
Unpublished / Not applicable
|
| Organism |
Homo sapiens |
| Experiment description |
Mesenchymal Stem Cell Exosomes: The Future MSC-based Therapy? |
| Authors |
"Ruenn Chai Lai, Ronne Wee Yeh Yeo, Soon Sim Tan, Bin Zhang, Yijun Yin, Newman Siu Kwan Sze, Andre Choo, and Sai Kiang Lim" |
| Journal name |
Mesenchymal Stem Cell Therapy
|
| Publication year |
2011 |
| Sample |
Mesenchymal stem cells |
| Sample name |
huES9.E1 |
| Isolation/purification methods |
HPLC |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Antobody array Mass spectrometry |
|
|
| 2 |
| Experiment ID |
488 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|CD81|CD63|GAPDH|SDCBP|LAMP1|TFRC|UCHL1|FLOT2|LAMP2|FLOT1|ICAM1|RAB5B|CD151|RAB35|TSG101|RAB5A|CD82
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Mesenchymal stem cells |
| Sample name |
UCMSC |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectometry |
|
|
| 3 |
| Experiment ID |
66 |
| MISEV standards |
|
✔
IEM
|
Biophysical techniques |
|
✔
TSG101|Alix|CD63|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
19199708
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). |
| Authors |
"Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, Yates JR" |
| Journal name |
JPR
|
| Publication year |
2009 |
| Sample |
Saliva |
| Sample name |
Saliva |
| Isolation/purification methods |
Differential centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [LTQ] Western blotting Immunoelectron Microscopy |
|
|
Protein-protein interactions for IGLV2-11 |
| |
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
|
No interactions are found.
|
|
Pathways in which IGLV2-11 is involved |
|
No pathways found
|
|
|